Siemens Healthineers has announced plans to develop a new radiopharmacy facility in Dunstable, reinforcing the growing importance of resilient infrastructure and specialist facilities management within healthcare environments.

The £26 million investment will establish what the company describes as the UK’s first 8X radiopharmacy, designed to produce PET radiopharmaceuticals at eight times the capacity of a conventional Radiopharma facility. The project aims to support increasing demand for PET/CT imaging services while improving long-term reliability and nationwide supply capabilities.

Beyond production capacity, the development reflects broader changes across healthcare estates, where operational resilience, compliance and specialist infrastructure management are becoming increasingly critical.

The Dunstable facility will combine advanced manufacturing technology with controlled environments and technical infrastructure. Plans include two high-energy cyclotrons, multiple clean rooms, hot cells, dedicated dispatch areas and an extensive quality control laboratory.

For facilities management teams operating in healthcare environments, these requirements highlight the complexity of maintaining highly regulated and business-critical assets. Specialist environments such as radiopharmacies depend on precise environmental controls, preventative maintenance programmes and operational continuity to support uninterrupted clinical services.

According to Siemens Healthineers, the facility has been designed with duplicate critical systems and built-in redundancy measures to strengthen reliability and reduce operational risk. The strategic location is also intended to support efficient logistics and enable same-day delivery to PET/CT centres across the UK.

The investment is expected to support both current diagnostic demand and future growth in theranostics and molecular therapies, areas that place increasing emphasis on integrated infrastructure planning and operational performance.

Siemens Healthineers currently operates more than 60 radiopharmacies globally, including 18 across Europe, supported by more than two decades of experience in the UK market.

As healthcare infrastructure continues to evolve, developments such as the Dunstable radiopharmacy demonstrate how facilities management is becoming increasingly central to delivering safe, reliable and future-ready clinical environments.

Read more about the radiopharmacy investment and healthcare infrastructure developments in the original report.